Found: 36
Select item for more details and to access through your institution.
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
A Case of Eosinophilic Granulomatosis with Polyangiitis Complicated with A IgG4 Related Disease Like Symptoms.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2715, doi. 10.1007/s10238-022-00949-3
- By:
- Publication type:
- Article
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1066, doi. 10.1007/s10637-022-01269-9
- By:
- Publication type:
- Article
The first lichen planus case coexisting bronchiolitis obliterans without malignant tumors.
- Published in:
- Pathology International, 2024, v. 74, n. 6, p. 352, doi. 10.1111/pin.13432
- By:
- Publication type:
- Article
Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 325, doi. 10.2147/JAA.S301444
- By:
- Publication type:
- Article
Real-world clinical outcomes of treatment with casirivimabimdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.
- Published in:
- International Journal of Medical Sciences, 2022, v. 19, n. 5, p. 834, doi. 10.7150/ijms.71132
- By:
- Publication type:
- Article
Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 1, p. 73, doi. 10.1002/cam4.4938
- By:
- Publication type:
- Article
Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 6971, doi. 10.1002/cam4.4220
- By:
- Publication type:
- Article
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1214-9
- By:
- Publication type:
- Article
A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild‑type non‑small cell lung cancer.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 220, doi. 10.1186/s13104-015-1214-9
- By:
- Publication type:
- Article
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 142, doi. 10.1159/000524077
- By:
- Publication type:
- Article
Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 3, p. 181, doi. 10.1159/000490949
- By:
- Publication type:
- Article
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2567, doi. 10.1111/1759-7714.15036
- By:
- Publication type:
- Article
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621
- By:
- Publication type:
- Article
Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3521, doi. 10.1111/1759-7714.13695
- By:
- Publication type:
- Article
Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2867, doi. 10.1111/1759-7714.13622
- By:
- Publication type:
- Article
Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1699, doi. 10.1111/1759-7714.12884
- By:
- Publication type:
- Article
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Two cases of idiopathic pulmonary fibrosis evaluated by dynamic digital radiography for diaphragmatic motion and disease progression.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Lung parenchymal involvement of primary bone marrow follicular lymphoma: a rare case study.
- Published in:
- Respirology Case Reports, 2018, v. 6, n. 3, p. 1, doi. 10.1002/rcr2.302
- By:
- Publication type:
- Article
Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
- Published in:
- Oncology, 2024, v. 102, n. 1, p. 30, doi. 10.1159/000533604
- By:
- Publication type:
- Article
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
- Published in:
- Oncology, 2021, v. 99, n. 9, p. 562, doi. 10.1159/000516745
- By:
- Publication type:
- Article
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1172, doi. 10.1634/theoncologist.2018-0676
- By:
- Publication type:
- Article
Pulmonary Infection Caused by Mycobacterium shinjukuense.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Pulmonary Infection Caused by Mycobacterium shinjukuense.
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 6, p. 958, doi. 10.1513/annalsats.201503-124le
- By:
- Publication type:
- Article
Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1080729
- By:
- Publication type:
- Article
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 9, p. 1, doi. 10.3390/medicina57090929
- By:
- Publication type:
- Article
Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02604-3
- By:
- Publication type:
- Article
Durvalumab after chemoradiotherapy in non‐small cell lung cancer with EGFR mutation: A real‐world study (HOT2101).
- Published in:
- Cancer Science, 2024, v. 115, n. 4, p. 1273, doi. 10.1111/cas.16094
- By:
- Publication type:
- Article
CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1898, doi. 10.1111/cas.13081
- By:
- Publication type:
- Article
Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
- Published in:
- Cancer Science, 2015, v. 106, n. 11, p. 1642, doi. 10.1111/cas.12808
- By:
- Publication type:
- Article
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 4, p. 915, doi. 10.1007/s12282-021-01228-x
- By:
- Publication type:
- Article